Evidence map›Paper›PMID 40978357›Full record

ArticleACS omega2025

Copper Foam-Supported Ce-MOF-808-On-SNW‑1 for Efficient Pararosaniline Photodegradation: A Novel MOF-On-COF/Substrate Coating Strategy.

Negin Khosroshahi, Parsa Azaddehghan, Pardis Malekmohamadi, Nooshin Gholhovallahi Ardakan, Vahid Safarifard

Abstract read
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Negin KhosroshahiDepartment of Chemistry, Iran University of Science and Technology, Tehran 16846-13114, Iran.
Parsa AzaddehghanDepartment of Chemistry, Iran University of Science and Technology, Tehran 16846-13114, Iran.
Pardis MalekmohamadiDepartment of Chemistry, Iran University of Science and Technology, Tehran 16846-13114, Iran.
Nooshin Gholhovallahi ArdakanDepartment of Chemistry, Iran University of Science and Technology, Tehran 16846-13114, Iran.
Vahid SafarifardDepartment of Chemistry, Iran University of Science and Technology, Tehran 16846-13114, Iran.ORCID https://orcid.org/0000-0003-4876-8257

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the face of growing environmental pollution, finding efficient and sustainable solutions for wastewater treatment has become a critical global challenge. In this context, photocatalysis has emerged as a promising technology for degrading harmful dyes and pollutants in water. In this work, a Ce-MOF-808-on-SNW-1 heterostructure was synthesized and immobilized onto a copper foam substrate through a spraying strategy. This method enabled uniform deposition of Ce-MOF-808 onto the SNW-1 covalent organic framework (COF), resulting in a significant enhancement of the visible-light-driven photocatalytic degradation of the toxic triphenylmethane dye pararosaniline (PRA). The Ce-MOF-808-on-SNW-1/Cu composite achieved an impressive degradation efficiency of 95.55% within 90 min (pH = 7), surpassing the performance of its components. The enhanced photocatalytic efficiency is attributed to its extended light absorption range and efficient charge separation. These improvements are a result of the synergistic interactions between the metal-organic framework (MOF) and COF structures, further facilitated by the conductive copper foam. Moreover, the composite exhibited outstanding stability and reusability over five cycles, demonstrating its potential for real-world wastewater treatment applications. This study underscores the significance of MOF-on-COF heterostructures and offers valuable insights into the rational design of advanced photocatalysts, paving the way for integrating hybrid porous materials into broader frameworks of sustainable environmental remediation and solar-driven catalysis.

Identifiers

PMID40978357
PMCPMC12444672

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.